Novel insights into mechanisms of food allergy and allergic airway inflammation using experimental mouse models

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 12, 2012, Pages 1483-1490

  Corazza, N ^a   Kaufmann, T ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

animal models; asthma; food allergy; Immunoglobulin E; innate immunity

Indexed keywords

BETA LACTOGLOBULIN; CD103 ANTIGEN; CD11B ANTIGEN; CD8ALPHA ANTIGEN; CHEMOKINE RECEPTOR CXCR1; FOOD ALLERGEN; GLYCOPROTEIN P 15095; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADAPTIVE IMMUNITY; ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANTIGEN EXPRESSION; BACTERIAL COLONIZATION; CHEMOTAXIS; DENDRITIC CELL; DISEASE MODEL; EOSINOPHIL; FOOD ALLERGY; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IN VIVO STUDY; INNATE IMMUNITY; NONHUMAN; PEANUT ALLERGY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TH2 CELL;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; FOOD HYPERSENSITIVITY; HUMANS; INFLAMMATION; MICE;

EID: 84867897754     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12065     Document Type: Review

References (70)

1. Holmes AM, Solari R, Holgate ST,. Animal models of asthma: value, limitations and opportunities for alternative approaches. Drug Discov Today 2011; 16: 659-670.
2. Nguyen TH, Stokes JR, Casale TB,. Future forms of immunotherapy and immunomodulators in allergic disease. Immunol Allergy Clin North Am 2011; 31: 343-365, x-xi.
3. Hong X, Wang X,. Early life precursors, epigenetics, and the development of food allergy. Semin Immunopathol 2012; 34: 655-669.
4. Samolinski B, Fronczak A, Kuna P, Akdis CA, Anto JM, Bialoszewski AZ, et al. Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy 2012; 67: 726-731.
5. Lieberman JA, Wang J,. Nonallergen-specific treatments for food allergy. Curr Opin Allergy Clin Immunol 2012; 12: 293-301.
6. Bates JH, Rincon M, Irvin CG,. Animal models of asthma. Am J Physiol Lung Cell Mol Physiol 2009; 297: L401-L410.
7. Sicherer SH, Sampson HA,. Food allergy. J Allergy Clin Immunol 2010; 125 (2 Suppl. 2): S116-S125.
8. Broide DH, Finkelman F, Bochner BS, Rothenberg ME,. Advances in mechanisms of asthma, allergy, and immunology in 2010. J Allergy Clin Immunol 2011; 127: 689-695.
9. Frossard CP, Hauser C, Eigenmann PA,. Antigen-specific secretory IgA antibodies in the gut are decreased in a mouse model of food allergy. J Allergy Clin Immunol 2004; 114: 377-382.
10. Karlsson MR, Johansen FE, Kahu H, Macpherson A, Brandtzaeg P,. Hypersensitivity and oral tolerance in the absence of a secretory immune system. Allergy 2010; 65: 561-570.
11. Hadis U, Wahl B, Schulz O, Hardtke-Wolenski M, Schippers A, Wagner N, et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 2011; 34: 237-246.
12. Smit JJ, Bol-Schoenmakers M, Hassing I, Fiechter D, Boon L, Bleumink R, et al. The role of intestinal dendritic cells subsets in the establishment of food allergy. Clin Exp Allergy 2011; 41: 890-898.
13. Curotto de Lafaille MA, Kutchukhidze N, Shen S, Ding Y, Yee H, Lafaille JJ,. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 2008; 29: 114-126.
14. Adel-Patient K, Wavrin S, Bernard H, Meziti N, Ah-Leung S, Wal JM,. Oral tolerance and Treg cells are induced in BALB/c mice after gavage with bovine beta-lactoglobulin. Allergy 2011; 66: 1312-1321.
15. Yamashita H, Takahashi K, Tanaka H, Nagai H, Inagaki N,. Overcoming food allergy through acquired tolerance conferred by transfer of Tregs in a murine model. Allergy 2012; 67: 201-209.
16. Fujihashi K, Dohi T, Kweon MN, McGhee JR, Koga T, Cooper MD, et al. gammadelta T cells regulate mucosally induced tolerance in a dose-dependent fashion. Int Immunol 1999; 11: 1907-1916.
17. Ke Y, Pearce K, Lake JP, Ziegler HK, Kapp JA,. Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance. J Immunol 1997; 158: 3610-3618.
18. Cardoso CR, Teixeira G, Provinciatto PR, Godoi DF, Ferreira BR, Milanezi CM, et al. Modulation of mucosal immunity in a murine model of food-induced intestinal inflammation. Clin Exp Allergy 2008; 38: 338-349.
19. Bol-Schoenmakers M, Marcondes Rezende M, Bleumink R, Boon L, Man S, Hassing I, et al. Regulation by intestinal gammadelta T cells during establishment of food allergic sensitization in mice. Allergy 2011; 66: 331-340.
20. Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011; 34: 794-806.
21. Schiavi E, Barletta B, Butteroni C, Corinti S, Boirivant M, Di Felice G,. Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy. Allergy 2011; 66: 499-508.
22. Zhang LL, Chen X, Zheng PY, Luo Y, Lu GF, Liu ZQ, et al. Oral Bifidobacterium modulates intestinal immune inflammation in mice with food allergy. J Gastroenterol Hepatol 2010; 25: 928-934.
23. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336: 489-493.
24. Schwarzer M, Repa A, Daniel C, Schabussova I, Hrncir T, Pot B, et al. Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization. Allergy 2011; 66: 368-375.
25. Barnes PJ,. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 2008; 8: 183-192.
26. Schroder NW, Maurer M,. The role of innate immunity in asthma: leads and lessons from mouse models. Allergy 2007; 62: 579-590.
27. Lambrecht BN,. Dendritic cells and the regulation of the allergic immune response. Allergy 2005; 60: 271-282.
28. Wills-Karp M,. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999; 17: 255-281.
29. Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MA, Muskens F, et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 2007; 13: 913-919.
30. Muller T, Robaye B, Vieira RP, Ferrari D, Grimm M, Jakob T, et al. The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy 2010; 65: 1545-1553.
31. Lamkanfi M, Dixit VM,. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 2012; 28: 137-161.
32. Schroder K, Tschopp J,. The inflammasomes. Cell 2010; 140: 821-832.
33. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K,. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196: 1645-1651.
34. Besnard AG, Guillou N, Tschopp J, Erard F, Couillin I, Iwakura Y, et al. NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant. Allergy 2011; 66: 1047-1057.
35. Allen IC, Jania CM, Wilson JE, Tekeppe EM, Hua X, Brickey WJ, et al. Analysis of NLRP3 in the development of allergic airway disease in mice. J Immunol 2012; 188: 2884-2893.
36. Kool M, Willart MA, van Nimwegen M, Bergen I, Pouliot P, Virchow JC, et al. An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity 2011; 34: 527-540.
37. Liew FY, Pitman NI, McInnes IB,. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010; 10: 103-110.
38. Ohno T, Morita H, Arae K, Matsumoto K, Nakae S,. Interleukin-33 in allergy. Allergy 2012; 67: 1203-1214.
39. Pushparaj PN, Tay HK, H'Ng SC, Pitman N, Xu D, McKenzie A., et al. The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A 2009; 106: 9773-9778.
40. Komai-Koma M, Brombacher F, Pushparaj PN, Arendse B, McSharry C, Alexander J, et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naive mice. Allergy 2012; 67: 1118-1126.
41. Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T,. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun 2009; 386: 181-185.
42. Kim YH, Park CS, Lim DH, Ahn SH, Son BK, Kim JH, et al. Beneficial effect of anti-interleukin-33 on the murine model of allergic inflammation of the lower airway. J Asthma 2012; 49: 738-743.
43. Kim YH, Yang TY, Park CS, Ahn SH, Son BK, Kim JH, et al. Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis. Allergy 2012; 67: 183-190.
44. Hayakawa H, Hayakawa M, Kume A, Tominaga S,. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007; 282: 26369-26380.
45. Yin H, Li XY, Liu T, Yuan BH, Zhang BB, Hu SL, et al. Adenovirus-mediated delivery of soluble ST2 attenuates ovalbumin-induced allergic asthma in mice. Clin Exp Immunol 2012; 170: 1-9.
46. Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH, et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006; 354: 697-708.
47. Choi JP, Kim YS, Kim OY, Kim YM, Jeon SG, Roh TY, et al. TNF-alpha is a key mediator in the development of Th2 cell response to inhaled allergens induced by a viral PAMP double-stranded RNA. Allergy 2012; 67: 1138-1148.
48. Mo JH, Kang EK, Quan SH, Rhee CS, Lee CH, Kim DY,. Anti-tumor necrosis factor-alpha treatment reduces allergic responses in an allergic rhinitis mouse model. Allergy 2011; 66: 279-286.
49. Kim J, McKinley L, Natarajan S, Bolgos GL, Siddiqui J, Copeland S, et al. Anti-tumor necrosis factor-alpha antibody treatment reduces pulmonary inflammation and methacholine hyper-responsiveness in a murine asthma model induced by house dust. Clin Exp Allergy 2006; 36: 122-132.
50. Hutchison S, Choo-Kang BS, Bundick RV, Leishman AJ, Brewer JM, McInnes IB, et al. Tumour necrosis factor-alpha blockade suppresses murine allergic airways inflammation. Clin Exp Immunol 2008; 151: 114-122.
51. Deveci F, Muz MH, Ilhan N, Kirkil G, Turgut T, Akpolat N,. Evaluation of the anti-inflammatory effect of infliximab in a mouse model of acute asthma. Respirology 2008; 13: 488-497.
52. Brightling C, Berry M, Amrani Y,. Targeting TNF-alpha: a novel therapeutic approach for asthma. J Allergy Clin Immunol 2008; 121: 5-10; quiz 11-12.
53. Hostettler N, Bianchi P, Gennari-Moser C, Kassahn D, Schoonjans K, Corazza N, et al. Local glucocorticoid production in the mouse lung is induced by immune cell stimulation. Allergy 2012; 67: 227-234.
54. von Gunten S, Kaufmann T,. Glucocorticoids 'on air'. Allergy 2012; 67: 144-146.
55. Kim SR, Lee KS, Park HS, Park SJ, Min KH, Moon H, et al. HIF-1alpha inhibition ameliorates an allergic airway disease via VEGF suppression in bronchial epithelium. Eur J Immunol 2010; 40: 2858-2869.
56. Kim SR, Lee KS, Park SJ, Min KH, Choe YH, Moon H, et al. Involvement of sirtuin 1 in airway inflammation and hyperresponsiveness of allergic airway disease. J Allergy Clin Immunol 2010; 125: 449-460. e414.
57. Huerta-Yepez S, Baay-Guzman GJ, Bebenek IG, Hernandez-Pando R, Vega MI, Chi L, et al. Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis. Allergy 2011; 66: 909-918.
58. Baay-Guzman GJ, Bebenek IG, Zeidler M, Hernandez-Pando R, Vega MI, Garcia-Zepeda EA, et al. HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation. Respir Res 2012; 13: 60.
59. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL,. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002; 277: 38205-38211.
60. Miele C, Rochford JJ, Filippa N, Giorgetti-Peraldi S, Van Obberghen E,. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J Biol Chem 2000; 275: 21695-21702.
61. Kim SR, Lee KS, Lee KB, Lee YC,. Recombinant IGFBP-3 inhibits allergic lung inflammation, VEGF production, and vascular leak in a mouse model of asthma. Allergy 2012; 67: 869-877.
62. Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS,. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995; 86: 1437-1443.
63. Simon HU,. Regulation of eosinophil and neutrophil apoptosis-similarities and differences. Immunol Rev 2001; 179: 156-162.
64. Sharma SK, Almeida FA, Kierstein S, Hortobagyi L, Lin T, Larkin A, et al. Systemic FasL neutralization increases eosinophilic inflammation in a mouse model of asthma. Allergy 2012; 67: 328-335.
65. Duez C, Tomkinson A, Shultz LD, Bratton DL, Gelfand EW,. Fas deficiency delays the resolution of airway hyperresponsiveness after allergen sensitization and challenge. J Allergy Clin Immunol 2001; 108: 547-556.
66. Ohta K, Yamashita N, Tajima M, Miyasaka T, Kawashima R, Nakano J, et al. In vivo effects of apoptosis in asthma examined by a murine model. Int Arch Allergy Immunol 2001; 124: 259-261.
67. Aldemir H, Bars R, Herouet-Guicheney C,. Murine models for evaluating the allergenicity of novel proteins and foods. Regul Toxicol Pharmacol 2009; 54 (3 Suppl.): S52-S57.
68. Berin MC, Mayer L,. Immunophysiology of experimental food allergy. Mucosal Immunol 2009; 2: 24-32.
69. Takeda K, Gelfand EW,. Mouse models of allergic diseases. Curr Opin Immunol 2009; 21: 660-665.
70. Yang PC, Xing Z, Berin CM, Soderholm JD, Feng BS, Wu L, et al. TIM-4 expressed by mucosal dendritic cells plays a critical role in food antigen-specific Th2 differentiation and intestinal allergy. Gastroenterology 2007; 133: 1522-1533.